Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days

This study has been completed.
Sponsor:
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01413737
First received: September 22, 2005
Last updated: August 9, 2011
Last verified: August 2011
  Purpose

This is a retrospective, descriptive analysis of (1) 30 day postoperative results of surgery for lung cancer, (2) 30 day outcome predictors - compared to an earlier similar study in the same hospital (St Olav University Hospital, Trondheim, Norway).


Condition
Lung Neoplasms

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Estimated Enrollment: 118
Study Start Date: January 2002
Estimated Study Completion Date: December 2004
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

lung cancer patients after surgery at university hospital

Criteria

Inclusion Criteria:

  • Lung cancer patients after surgery in 2002-2004 at dept for Heart and Lung Surgery, St.Olavs University Hospital, Trondheim, Norway.

Exclusion Criteria:

  • Carcinoid tumor, small-cell lung cancer, lung metastases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01413737

Locations
Norway
NTNU
Trondheim, Sør-Trøndelag, Norway, 7006
NTNU
Trondheim, Norway
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Study Chair: Rune Haaverstad, Ph.D NTNU
  More Information

Publications:
Responsible Party: Haaverstad, Rune, Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT01413737     History of Changes
Other Study ID Numbers: 4.2005.1826
Study First Received: September 22, 2005
Last Updated: August 9, 2011
Health Authority: Norway: Norwegian Social Science Data Services

Additional relevant MeSH terms:
Lung Neoplasms
Lung Diseases
Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms

ClinicalTrials.gov processed this record on November 19, 2014